Form 990 for tax year 2022

What the amendment changed

Compared with the latest return for 2022 , filed 17 December 2025. matched by us Only the return's totals, a 990-PF's accounting method and the names listed in Part VII (Part VIII on a 990-PF) are compared. We relate returns by organization, tax year and form, and order them by each return's own timestamp; the filer's own "amended return" checkbox is a separate fact.

Those are the same on the two returns, so the amendment changed something else.

Totals

Total revenue

$30,061,391

Total expenses

$27,499,747

Contributions and grants received

$28,539,924

Grants paid

$14,140,651

Program service revenue

$1,511,772

Investment income

$9,695

Other revenue

$0

Total assets, end of year

$28,649,661

Total liabilities, end of year

$11,484,704

Net assets or fund balances, end of year

$17,164,957

Program services expenses (Part IX)

— not reported

Management and general expenses

— not reported

Fundraising expenses

— not reported

Program service expenses (Part III)

— not reported

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Mission and programs · 2022

• ARMI and its BioFabUSA Institute accomplishes its mission through key activities, such as the following: Collaborates with community, local, State, and Federal stakeholders to advance the U.S bioeconomy and fuel inclusive economic growth, including by creating pathways and access to jobs in the biofabrication industry. Provides wrap-around commercialization services for tissue engineering and enabling technology companies. These efforts de-risk and accelerate translation of impactful technologies to market. Funds technical projects that address many of the common manufacturing challenges faced by companies in the field of tissue engineering. This will allow tissue engineering and enabling technology companies to focus their time and resources on product-specific challenges, moving the entire industry forward more quickly and efficiently. Funds education and workforce development (EWD) projects that address the industry need for trained employees with a broad base of biomanufacturing skills and specific expertise. This pressing need can otherwise constrain the growth of tissue engineering and enabling technology companies. In coordination with organizations in the field of regenerative manufacturing, develops roadmaps of technical and EWD needs for the field. These roadmaps guide the work of organizations in the field of regenerative manufacturing and guide the selection of projects. Hosts, sponsors, and participates in conferences and workshops that convene organizations that support regenerative manufacturing. These events allow for shared learning related to technical, regulatory, workforce, and financial challenges and solutions. Shares information about best practices and innovations in the field via various fora and online resources.NextFab accomplishes is mission through key activities, such as the following: Establish framework for demand-based Advisory Panels to conduct expert seminars and other thought-leadership efforts. Develop commercial advisory and consulting programs designed to accelerate adoption of advanced technologies. Provide shared facilities to accelerate advanced technologies. Performs projects of interest to U.S. Department of Health and Human Services.

As filed on the 2022 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

• DEKA Integrated Solutions Corp

  $4,163,867

  BiofabUSA CARES Act Funded Program (DOD-Directed)

• MxD USA

  $872,244

  BioFabUSA CARES Act Funded Program (DoD-Directed)

• Advanced Solutions Inc

  $663,432

  See Part IV

• Pluristyx

  $643,723

  See Part IV

• X-Therma

  $632,120

  Subaward pursuant to our Technology Investment Agreement with the Government

• Washington University

  $497,249

  Subaward pursuant to our grant with a private foundation

• Organamet Bio

  $489,766

  Subaward pursuant to our Technology Investment Agreement with the Government

• University of Florida

  $378,792

  Subaward pursuant to our Technology Investment Agreement with the Government

• Terasaki Institute for Biomedical Innovat

  $316,224

  Subaward pursuant to our Technology Investment Agreement with the Government

• The General Hospital Corporation dba Massachusetts General Hospital

  $308,773

  NextFab Bilateral Health Tech Hub Program (HHS-Directed)

The 10 largest by cash amount. The API serves every itemized grant.

Taxable family on this return

Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.

Provenance

Return type

form_990

Tax year

2022

Filed

15 November 2023

IRS schema version

2022v5.0

Source object

202323199349327667

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.